Back to Search Start Over

CYP3A4*22 may increase bleeding risk in ticagrelor users.

Authors :
Liedes H
Pajula J
Vuorinen AL
De Pretis F
van Gils M
Harno K
Lehto M
Niemi M
Lähteenmäki J
Source :
Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2023 Aug; Vol. 133 (2), pp. 202-207. Date of Electronic Publication: 2023 May 31.
Publication Year :
2023

Subjects

Subjects :
Humans
Ticagrelor adverse effects
Cytochrome P-450 CYP3A
Hemorrhage chemically induced
Platelet Aggregation Inhibitors adverse effects
Treatment Outcome
Percutaneous Coronary Intervention
Acute Coronary Syndrome

Details

Language :
English
ISSN :
1742-7843
Volume :
133
Issue :
2
Database :
MEDLINE
Journal :
Basic & clinical pharmacology & toxicology
Publication Type :
Academic Journal
Accession number :
37162098
Full Text :
https://doi.org/10.1111/bcpt.13884
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details